Delivery Order SPE2DB20D3303-SPE2DB25FA2YY
Award Date 8/25/25
Potential Completion Date 8/26/25
Potential Value $9.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $55,877.06 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 360 mg Deferasirox tablets, a medication used to treat chronic iron overload. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 22, 2025, for Deferiprone 500 mg tablets (100-count packages) valued at $6,470.85. This competitively awarded, firm fixed-price contract is funded by the Medical Supply Chain, a defense-focused federal procurement entity, with an ultimate completion date of July 23, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product Deferasirox 500 mg tablets for suspension. The contract has a ceiling value of $2,455.30 and a period of performance through March 21, 2024. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor on this delivery order, which is issued under a larger...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DEFERASIROX 360 MG TABLET 30S, a medical product, with a ceiling value of $54,663.84 and a performance period through May 20, 2025. The contract is a firm-fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $40,063.08, is for the delivery of Deferiprone 1,000 mg tablets to support military healthcare programs. The contract is a firm-fixed price type, with an ultimate completion date of January 18, 2024. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide DEFERIPRONE 500 MG TABLET 100S. The contract has a ceiling value of $36,056.43 and a completion date of June 12, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DEFERASIROX 360 MG TABLET 30S. The firm fixed price contract has a potential value of $13,105.98 and a performance completion date of December 29, 2023. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to supply pharmaceuticals, medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,441.12 on August 11, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 12, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The company serves as...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $61,743.15 from the Defense Logistics Agency's Medical Supply Chain on August 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $28,728.06, is for the supply of JADENU 360 MG TABLET 30S, a specialty pharmaceutical product. The award has an ultimate completion date of October 16, 2024 and was made on October 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999...